A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

An indication for a pacemaker or implantable cardioverter-defibrillator (ICD) in a patient with an intracardiac shunt requires a balancing of the risks and benefits associated with a transvenous ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Complications related to transvenous pacemakers have ...

Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

Nevertheless, despite the recommendations to not routinely consider advanced age as one of the most important risk factors for periprocedural complications of transvenous lead extraction (TLE), ...

NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...

Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

One of the largest and longest follow-ups of patients implanted with the subcutaneous-lead implantable cardioverter defibrillator (S-ICD), now marketed as the EMBLEM S-ICD (Boston Scientific), paints ...